SS Innovations International Inc. (NASDAQ: SSII) has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised over $100 million during her career. The appointment comes as the company continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding its international footprint.
Romano joins SS Innovations after serving as CFO at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn and strengthen the company's balance sheet. Her experience is expected to be instrumental as SS Innovations prepares for U.S. FDA review (https://nnw.fm/yY4UM) and broader commercialization of the SSi Mantra platform.
The leadership strengthening coincides with the company's recent graduation of the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program. The program welcomed 33 healthcare professionals from seven countries, underscoring the company's emphasis on surgeon education alongside technology deployment. This initiative is part of SS Innovations' strategy to build a skilled user base for its robotic systems worldwide.
The SSi Mantra is a versatile surgical robotic system designed for multi-specialty procedures, including cardiac, thoracic, and general surgeries. The company has been actively expanding its presence in markets such as India, the Middle East, and Latin America, where it has received regulatory approvals and performed successful surgeries. The U.S. market represents a significant growth opportunity, and FDA clearance is a key milestone that could unlock substantial revenue potential.
Investors are closely watching SS Innovations' progress, as the global surgical robotics market is projected to grow rapidly, driven by demand for minimally invasive procedures. The company's dual focus on technology and training positions it to compete with established players like Intuitive Surgical. Romano's appointment adds financial discipline and capital markets expertise, which are critical for funding R&D, regulatory processes, and commercial expansion.
For more information on SS Innovations and its latest developments, visit the company's newsroom at https://nnw.fm/SSII.
